| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2022 | NUMENTUS TECHNOLOGIES INC | 333 RAVENSWOOD AVE | MENLO PARK | CA | 94025-3453 | SAN MATEO | USA | R21CA236686 | Decoding Individual Exosomes in Cancer | 000 | 2 | NIH | 10/17/2024 | $0 |
| | 2025 | 2021 | NUMENTUS TECHNOLOGIES INC | 333 RAVENSWOOD AVE | MENLO PARK | CA | 94025-3453 | SAN MATEO | USA | R43AG074869 | Single Exosome Technology for Alzheimer's Disease | 000 | 1 | NIH | 12/19/2024 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $596,858 ) |
| | 2024 | 2024 | NUMENTUS TECHNOLOGIES INC | 333 RAVENSWOOD AVE | MENLO PARK | CA | 94025-3453 | SAN MATEO | USA | R43AI181390 | Rapid, versatile PCR | 000 | 1 | NIH | 2/21/2024 | $297,872 |
| | 2024 | 2024 | NUMENTUS TECHNOLOGIES INC | 333 RAVENSWOOD AVE | MENLO PARK | CA | 94025-3453 | SAN MATEO | USA | R43GM156162 | High-Throughput High-Content Nanoscale Extracellular Vesicle Analysis | 000 | 1 | NIH | 7/9/2024 | $298,999 |
| | 2024 | 2022 | NUMENTUS TECHNOLOGIES INC | 333 RAVENSWOOD AVE | MENLO PARK | CA | 94025-3453 | SAN MATEO | USA | R43AI167263 | Very rapid, low cost multiplexed test for SARS, Influenza A and Influenza B Resubmission | 000 | 1 | NIH | 7/29/2024 | -$13 |
|
| Issue Date FY: 2023 ( Subtotal = $599,485 ) |
| | 2023 | 2023 | NUMENTUS TECHNOLOGIES INC | 333 RAVENSWOOD AVE | MENLO PARK | CA | 94025-3453 | SAN MATEO | USA | R43MH135772 | High-speed hyperspectral imaging for highly multiplexed immunofluorescence imaging | 000 | 1 | NIH | 8/23/2023 | $300,691 |
| | 2023 | 2023 | NUMENTUS TECHNOLOGIES INC | 333 RAVENSWOOD AVE | MENLO PARK | CA | 94025-3453 | SAN MATEO | USA | R43AI174576 | Bacteria and pathogen characterizations using outer membrane vesicles | 000 | 1 | NIH | 7/3/2023 | $298,794 |
| | 2023 | 2021 | NUMENTUS TECHNOLOGIES INC | 333 RAVENSWOOD AVE | MENLO PARK | CA | 94025-3453 | SAN MATEO | USA | R43AG074869 | Single Exosome Technology for Alzheimer's Disease | 000 | 1 | NIH | 7/31/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $511,870 ) |
| | 2022 | 2022 | NUMENTUS TECHNOLOGIES INC. | 333 RAVENSWOOD AVE | MENLO PARK | CA | 94025-3453 | SAN MATEO | USA | R21CA236686 | Decoding Individual Exosomes in Cancer | 001 | 2 | NIH | 6/22/2022 | $226,273 |
| | 2022 | 2022 | NUMENTUS TECHNOLOGIES INC. | 333 RAVENSWOOD AVE | MENLO PARK | CA | 94025-3453 | SAN MATEO | USA | R43AI167263 | Very rapid, low cost multiplexed test for SARS, Influenza A and Influenza B Resubmission | 000 | 1 | NIH | 4/12/2022 | $285,597 |
| | 2022 | 2021 | NUMENTUS TECHNOLOGIES INC. | 333 RAVENSWOOD AVE | MENLO PARK | CA | 94025-3453 | SAN MATEO | USA | R21CA236686 | Decoding Individual Exosomes in Cancer | 000 | 1 | NIH | 12/22/2021 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $532,713 ) |
| | 2021 | 2021 | NUMENTUS TECHNOLOGIES INC. | 333 RAVENSWOOD AVE | MENLO PARK | CA | 94025-3453 | SAN MATEO | USA | R43AG074869 | Single Exosome Technology for Alzheimer's Disease | 000 | 1 | NIH | 9/14/2021 | $299,151 |
| | 2021 | 2021 | NUMENTUS TECHNOLOGIES INC. | 333 RAVENSWOOD AVE | MENLO PARK | CA | 94025-3453 | SAN MATEO | USA | R21CA236686 | Decoding Individual Exosomes in Cancer | 000 | 1 | NIH | 6/29/2021 | $233,562 |
|
|
